Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Stock Short Interest Drops 87.9%

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the recipient of a significant decline in short interest in September. As of September 15th, there was short interest totaling 3,321 shares, a decline of 87.9% from the August 31st total of 27,525 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average trading volume of 8,922 shares, the days-to-cover ratio is currently 0.4 days.

Institutional Trading of Virtus LifeSci Biotech Products ETF

A hedge fund recently bought a new stake in Virtus LifeSci Biotech Products ETF stock. Comprehensive Financial Planning Inc. PA acquired a new position in shares of Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,971 shares of the company’s stock, valued at approximately $557,000. Comprehensive Financial Planning Inc. PA owned about 1.27% of Virtus LifeSci Biotech Products ETF at the end of the most recent quarter.

Virtus LifeSci Biotech Products ETF Price Performance

Shares of NYSEARCA:BBP traded up $0.03 during trading on Friday, reaching $104.66. 8,019 shares of the stock were exchanged, compared to its average volume of 8,724. Virtus LifeSci Biotech Products ETF has a 1-year low of $68.05 and a 1-year high of $110.05. The stock has a fifty day moving average of $102.80 and a two-hundred day moving average of $93.03.

Virtus LifeSci Biotech Products ETF Company Profile

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.